GOVX
GeoVax Labs, Inc. New
Nasdaq · usd
GeoVax Labs, Inc. New (GOVX) trades at $1.81 (-5.24%) as of 7:59:59 PM EST on Nov 20, 2026, -64.54% over the past month. Market cap is $985.46K, with 1.0 days to cover in short interest.
Stock performance
How GeoVax Labs, Inc. New (GOVX) stock has performed from one day to one year, with its 52-week range.
- 1D
- -5.24%
- 1W
- +6.16%
- 1M
- -64.54%
- YTD
- -98.24%
- 1Y
- -99.21%
- 52-wk range
- $1.51 – $270.66
Key statistics
Today's trading snapshot for GOVX: day range, open, previous close, volume and market cap.
- Day range
- $1.75 – $1.95
- Open
- $1.85
- Prev close
- $1.91
- Volume
- 4.23M
- Market cap
- $985.46K
- Shares out
- 544.45K
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for GeoVax Labs, Inc. New: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 0.86
- P/FCF
- —
- ROE
- -1591.5%
- ROA
- -533.3%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 20, 2026
8-K filings
Material corporate events GeoVax Labs, Inc. New has disclosed to the SEC on Form 8-K.
- Executive compensation changeNov 19, 2026
Under the CFO Consulting Agreement, ... The Company will pay BPC $10,000 per month, plus applicable taxes ... BPC is eligible to receive a performance-based bonus ... and is eligible to participate in the Company's compensation, bonus incentive and equity-based compensation plans.
- Charter amendmentNov 12, 2026
On November 10, 2026, GeoVax Labs, Inc. filed a Certificate of Amendment to our Certificate of Incorporation effecting a 1-for-24 reverse stock split. The rights and privileges of the holders of shares of Common Stock are substantially unaffected by the Reverse Stock Split.
- Executive officer appointmentNov 9, 2026
Effective November 8, 2026, the Board of Directors appointed Tyler O'Brien as interim Chief Executive Officer. Until a permanent principal executive officer is appointed or designated, Mr. O'Brien will perform the functions of principal executive officer.
- Ceo departureNov 6, 2026
On November 5, 2026, David A. Dodd was terminated as President and Chief Executive Officer of the GeoVax Labs, Inc. (the "Company"), effective immediately. Mr. Dodd remains a director of the Company and the Chairman of the Board of Directors.
- Director appointmentOct 27, 2026
The remaining members of the Company's Board of Directors appointed three individuals designated by the Lender, Steven Brown, Tyler O'Brien and Manpreet Uppal as directors. The Lender Board Nominees constitute three of the five members of the Board of Directors and a majority of each of its committees.
Dividend history and stock splits
GeoVax Labs, Inc. New's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-24Nov 11, 2026
- 1-for-25Jan 12, 2026
- 1-for-15Jan 31, 2024
GOVX short interest
How heavily GOVX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 175.9K
- Avg volume
- 184.19K
As of · reported to FINRA twice monthly.
GOVX news
The latest news and headlines about GeoVax Labs, Inc. New (GOVX).
- Is Co-Diagnostics National Security’s Next Diagnostic Pick?positiveInvesting.com· May 28, 2026
- WHO Africa Chief Warns It's A 'Big Mistake' To Underestimate Ebola Outbreak As Deadly Virus Spreads Beyond CongopositiveBenzinga· May 22, 2026
- GeoVax Stock Higher As Company Highlights MVA Platform For Ebola ThreatspositiveBenzinga· May 20, 2026
- Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research PrioritiespositiveBenzinga· Jul 16, 2025
- Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live streamneutralGlobeNewswire Inc.· Jul 16, 2025
Frequently asked questions
What is the GeoVax Labs, Inc. New (GOVX) stock price today?
GeoVax Labs, Inc. New (GOVX) is trading at $1.81 (-5.24% on the day) as of 7:59:59 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is GeoVax Labs, Inc. New?
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms.
What is the short interest in GOVX?
As of Oct 30, 2026, GOVX has 175.9K shares short and 1.0 days to cover.
What exchange is GOVX listed on?
GeoVax Labs, Inc. New (GOVX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of GOVX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a GOVX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.